PhylloTech Nabs SBIR Grant
PhylloTech, a biopesticide developer and plant biotechnology company, announced today that it is the recipient of the second phase of a National Science Foundation SBIR contract worth $750,000. According to a…
Category Archives: Biotech
Cellectar Sees Benefits in Study
Cellectar Biosciences announced recently a clinical benefit rate of 80 percent from its Phase I clinical study of CLR 131 in patients with relapsed or refractory multiple myeloma. “The efficacy…
Propeller, MIR to Collaborate
Propeller Health announced today that it will collaborate with Medical International Research (MIR), a global leader in spirometry, oximetry and telemedicine, to integrate several of MIR’s mobile and clinical spirometers into the…
OnLume Earns $300K SBIR Grant
OnLume, a medical device company developing surgical lighting technology, is the recipient of a Phase I SBIR grant through the National Cancer Institute SBIR worth $300,000. “At OnLume, we believe…
Cellectar Makes $8M Public Offering
Cellectar Biosciences today announced the effective price of $1.50 per share of common stock of an underwritten public offering to raise approximately $8 million. According to a release, Cellectar will use…
MVI Vaccine Shows ‘Promise’ vs. Cancer
Madison Vaccines Incorporated (MVI) announced today it will present data at the Society for Immunotherapy of Cancer’s Annual Meeting on Nov. 11 in National Harbor, Md., that has “promise” to stimulate an immune…
Propeller Gets 8th FDA Clearance
Propeller Health received clearance from the U.S. Food and Drug Administration on its Propeller platform for use with GlaxoSmithKline’s Ellipta inhaler, the company announced today. “Today, we are pleased to announce…
Regenerative Meds Company Launches
JangoBio recently announced its founding as a biotech company focused on restoring hormones to their optimal youthful levels. The pre-clinical stage company was formed in 2015 and is developing new therapies to sustainably…
Propeller Health Closes $21.5M Series C
Propeller Health announced today that it completed a $21.5 million Series C financing round. According to a release, the funds will be used to expand the company’s digitally guided therapy…
Cologuard’s Coverage Expands
Exact Sciences’ Cologuard continues to expand its coverage as it is now included under TRICARE’s preventive services policies, the company announced today. TRICARE provides benefits to 9.4 million active-duty, reserve and…
